These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Report on practical experiences with Lyndiol and Lyndiol 2.5]. Falus M Med Welt; 1967 Dec; 50():3089-92. PubMed ID: 5610831 [No Abstract] [Full Text] [Related]
3. [Clinical study of a new ovulation inhibitor]. Lecart C Schweiz Rundsch Med Prax; 1970 Jun; 59(25):933-6. PubMed ID: 5513424 [No Abstract] [Full Text] [Related]
4. Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol). Moses LE; Goldzieher JW; Moses IG Fertil Steril; 1969; 20(5):715-28. PubMed ID: 5822858 [No Abstract] [Full Text] [Related]
6. Clinical evaluation of lynestrenol (Lyndiol) as an oral contraceptive agent. Connell EB; Stone ML J Am Med Womens Assoc; 1967 Dec; 22(12):951-5. PubMed ID: 4230214 [No Abstract] [Full Text] [Related]
7. [Pharmacological inhibition and stimulation of ovulation]. Tausk M Wien Klin Wochenschr; 1968 Jul; 80(29):561-7. PubMed ID: 4303154 [No Abstract] [Full Text] [Related]
8. [Preliminary results of comparative trials of oral contraceptives]. Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452 [No Abstract] [Full Text] [Related]
9. [Clinico-pathological study of the effects of contraceptive treatment with mestranol-lynestrol by a sequential type method]. Arrizabalaga Amarelo R; Rojas M; Corral Gallardo J Ginecol Obstet Mex; 1972 Apr; 31(186):419-32. PubMed ID: 5028610 [TBL] [Abstract][Full Text] [Related]
10. [Hormone excretion during and after treatment with Lyndiol 2.5]. Keller M Gynaecologia; 1967; 163(4):187-98. PubMed ID: 6029674 [No Abstract] [Full Text] [Related]
11. [Change in calcium metabolism in women during prolonged treatment with 2,5 mg of Lyndiol]. Chef R Bull Soc R Belge Gynecol Obstet; 1967; 37(4):255-63. PubMed ID: 5619668 [No Abstract] [Full Text] [Related]
13. [Clinical experiences with Ovosiston for inhibition of ovulation]. Kühne D Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201 [No Abstract] [Full Text] [Related]
14. [Thrombelastography in anovulatory therapy with estroprogestogens]. Torre GC; Rosso-Chioso M; Chisalé E; Gargiulo T; Pallotti A; Sciandra F; Piras A Riv Ital Ginecol; 1980; 59(2-3):197-211. PubMed ID: 7256100 [No Abstract] [Full Text] [Related]
15. [Blood glucose in women on Noracycline and Gestranol]. Jabloński K; Giermańska T; Filc-Bauer A Pol Tyg Lek; 1972 Oct; 27(43):1676-8. PubMed ID: 4639621 [No Abstract] [Full Text] [Related]
17. [Modification of glucose tolerance and plasma insulin concentration by ovulation inhibitors]. Waldhäusl W; Beringer A; Schneider W Geburtshilfe Frauenheilkd; 1969 Jul; 29(7):611-7. PubMed ID: 4184205 [No Abstract] [Full Text] [Related]
18. [Cyto-hormonal diagnosis during use of various oral contraceptives]. Loch EG; Tenhaeff D; Lohmeyer H Z Geburtshilfe Gynakol; 1970 Jun; 172(3):261-6. PubMed ID: 4102712 [No Abstract] [Full Text] [Related]
19. Cytological effects of two contraceptives. Kabarity A; Khodari S Genetica; 1967; 38(2):184-90. PubMed ID: 5586876 [No Abstract] [Full Text] [Related]
20. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol". Farbiszewski R; Kurowska T Thromb Diath Haemorrh; 1970 Oct; 24(1):304-7. PubMed ID: 5483970 [No Abstract] [Full Text] [Related] [Next] [New Search]